Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Typesort descending Project # RFA # PI/Project Leader Institution Title Status
2000 R43 PAR-99-101 MOEN, PHILLIP T ONE CELL SYSTEMS, INC NOVEL METHOD FOR DETECTING NON-HODGKIN'S LYMPHOMA Complete
2002 R43 PAR-01-105 TRNOVSKY, JAN ONE CELL SYSTEMS, INC METHOD FOR DETECTING CHRONIC MYELOGENOUS LEUKEMIA CELLS Complete
2018 R43 PAR-18-303 LIM, MARK AMBERGEN, INC Highly Multiplexed Nanoscale Mass Spectrometric Imaging of Cancer Tissues Active
1999 R43 PAR-98-066 MONFORTE, JOSEPH A GENETRACE SYSTEMS, INC. EXPRESSION MONITORING OF MULTIPLEXED CANCER GENE SETS Complete
2017 R43 PAR-13-327 PEYTAVI, REGIS BLUENOVO BIOSYSTEMS, INC. Detection of Methylation and Translocation Events by Novel Sequencing Technology Complete
2000 R43 PAR-99-101 SERBEDZIJA, GEORGE N PHYLONIX PHARMACEUTICALS, INC. WHOLE ANIMAL APOPTOSIS ASSAY FOR CANCER DRUG SCREENING Complete
2002 R43 PAR-01-105 LATHAM, GARY J AMBION, INC. ENZYMATIC TOOLS FOR DEGRADING TISSUE AND PRESERVING RNA Complete
2018 R43 PAR-18-303 LEE, LY JAMES NANOMATERIAL INNOVATION, LTD Molecular Beacons in Lipoplex Nanoparticles for Extracellular Vesicles Based Cancer Diagnosis Complete
1999 R43 PAR-98-066 RICHTERICH, PETER CODONCODE CORPORATION SOFTWARE FOR SEQUENCING BASED MUTATION DETECTION Complete
2020 R43 PAR-18-303 WARREN, CHRISTOPHER L PROTEOVISTA, LLC Development Of The High Throughput Apt-snap Platform For Rapid Identification Ofnuclease-resistant Rna Aptamers Against P53 Missense Mutations Active
2000 R43 PAR-99-101 KOGON, ALEX A BIOLINX, LLC THOMSEN-FRIEDERICH ANTIGEN ASSAY FOR CANCER SCREENING Complete
2002 R43 PAR-01-105 HANNA, MICHELLE M RIBOMED BIOTECHNOLOGIES, INC. RAPID ANALYSIS OF CPG METHYLATION CHANGES IN CANCER Complete
2018 R43 PAR-18-303 SCHOETTLE, LOUIS GEMNEO BIOSCIENCE, INC. Origami Nanoprobes for Large-Scale Single-Cell Analysis of Lymphocytes Complete
2019 R43 PAR-18-303 KHODAVERDIAN, VARANDT Y. NUPROBE USA, INC. Allele selective enrichment for targeted profiling of rare cancer mutations via low-depth sequencing Complete
1999 R43 PAR-98-066 GOLDRICK, MARIANNA M AMBION, INC. DETECTION AND QUANTITATION OF FUSION MRNAS IN LEUKEMIA Complete
2000 R43 PAR-99-101 WOOD, KATHERINE A TREVIGEN, INC. HIGH THROUGHPUT DNA REPAIR CAPACITY ASSAY Complete
2002 R43 PAR-01-105 JOHNSON, PAUL H EPIGENX PHARMACEUTICALS TECHNOLOGY FOR GENOME-WIDE CANCER METHYLATION PROFILING Complete
2019 R43 PAR-18-303 WARREN, CHRISTOPHER L PROTEOVISTA, LLC Development of the High Throughput APT-SNAP Platform for Rapid Identification ofNuclease-Resistant RNA Aptamers against p53 Missense Mutations Complete
1999 R43 PAR-98-066 CRONIN, MAUREEN T. PROTOGENE LABORATORIES, INC. DEVELOPMENT OF DNA MICROARRAY FABRICATION METHOD Complete
2000 R43 PAR-99-101 RENARD, ANDRE INTERGEN COMPANY PYRENE-CONTAINING PROBES FOR MUTATION DETECTION Complete
2002 R43 PAR-01-105 MC GARRITY, GERARD J. INTRONN, INC. PRE-MRNA TRANS-SPLICING FOR MOLECULAR IMAGING OF CANCER Complete
2019 R43 PAR-18-303 KASOJI, SANDEEP TRIANGLE BIOTECHNOLOGY, INC. SBIR: Technology for Overcoming Bottlenecks in Chromatin Extraction from Challenging Biological Samples Complete
1999 R43 PAR-98-066 WIKTOR, PETER J. ENGINEERING ARTS PIEZO ELECTRIC PIPETTING TECHNOLOGY FOR DNA ANALYSIS Complete
2000 R43 PAR-99-101 MOEN, PHILLIP T ONE CELL SYSTEMS, INC DISCRETE ASSAY FOR INTEGRATED HPV DNA IN CERVICAL CELLS Complete
2005 R43 RFA-CA-05-006 KIM, RAYMOND GENEPRISM, INC. MULTIPLEXED PROTEIN BIOCHIP ASSAYS--SIGNAL AMPLIFICATION Complete
2003 R44 PAR-99-101 GAO, JUN CALIBRANT BIOSYSTEMS, INC. ELECTRONIC PROTEIN TRANSFER FOR PROTEOME ANALYSIS Complete
2002 R44 PAR-99-101 ZEBALA, JOHN A SYNTRIX BIOSYSTEMS, INC. LIGHT-UP PNA ARRAYS Complete
2000 R44 PAR-99-101 LEVENSON, RICHARD M. CAMBRIDGE RESEARCH AND INSTRUMENTATION SIMPLE, LOW-COST, ULTRA-RAPID SPECTRAL IMAGING PLATFORM Complete
2002 R44 PAR-01-105 DREES, BETH E ECHELON BIOSCIENCES, INC. PHOSPHOINOSITIDE 3-KINASE ASSAYS IN CANCER DIAGNOSIS Complete
2000 R44 PAR-98-066 LIFSHITZ, NADIA BIOPHOTONICS CORPORATION HIGH THROUGHPUT, HIGH RESOLUTION DNA SEQUENCING Complete
2002 R44 PAR-01-105 MOEN, PHILLIP T ONE CELL SYSTEMS, INC DISCRETE ASSAY FOR INTEGRATED HPV DNA IN CERVICAL CELLS Complete
2000 R44 PAR-98-066 ANDERSON, N LEIGH LARGE SCALE BIOLOGY CORPORATION PROTEOMIC TECHNOLOGIES FOR CANCER RESEARCH Complete
2005 R44 RFA-CA-05-006 RUSH, JOHN CELL SIGNALING TECHNOLOGY, INC. IMMUNOAFFINITY ISOLATION OF PHOSPHOPEPTIDES Complete
1999 R44 PAR-98-066 LIFSHITZ, NADIA BIOPHOTONICS CORPORATION HIGH THROUGHPUT, HIGH RESOLUTION DNA SEQUENCING Complete
2005 R44 PAR-01-105 BALGLEY, BRIAN M. CALIBRANT BIOSYSTEMS, INC. INTEGRATED TOP-DOWN/BOTTOM-UP COMPREHENSIVE PROTEOMICS Complete
1999 R44 PAR-98-066 ANDERSON, N LEIGH LARGE SCALE BIOLOGY CORPORATION PROTEOMIC TECHNOLOGIES FOR CANCER RESEARCH Complete
2008 R44 RFA-CA-07-039 GUO, BAOCHUAN GLC BIOTECHNOLOGY, INC. MMPA: A NOVEL MULTIPLEXING METHYLATION ANALYSIS TECHNOLOGY Complete
2006 R44 RFA-CA-06-006 BROWN, DAVID M AMBION DIAGNOSTICS, INC. MIRNA PROFILING IN FIXED CANCER SAMPLES Complete
2008 R44 RFA-CA-07-041 LEE, BRIAN W IMMUNOCHEMISTRY TECHNOLOGIES, LLC NEW FLUORESCENT CASPASE DETECTION PROBES TO LABEL APOPTOTIC TUMOR CELLS IN VIVO Complete
2006 R44 RFA-CA-06-005 BRADY, ERIK D MICROCOSM, INC. ENHANCED CANCER MICROARRAY Complete
2008 R44 RFA-CA-07-039 LIM, MARK AMBERGEN, INC ADVANCED TECHNOLOGY FOR ASSAYING CANCER-DRUG RESISTANCE Complete
2006 R44 RFA-CA-06-005 LU, PETER S. ARBOR VITA CORPORATION A NOVEL DIAGNOSTIC ASSAY FOR ONCOGENIC HUMAN PAPILLOMAVIRUSES Complete
2020 R44 PAR-18-303 FRIEDA, KIRSTEN SPATIAL GENOMICS, INC. Spatial and single cell analysis of tumor microenvironment by seqFISH+ Complete
2008 R44 RFA-CA-07-041 LEE, PHILIP J CELLASIC CORPORATION MICROFLUIDIC PLATFORM FOR CANCER CELL CULTURE AND ANALYSIS Complete
2008 R44 RFA-CA-06-006 BROWN, DAVID M AMBION DIAGNOSTICS, INC. MIRNA PROFILING IN FIXED CANCER SAMPLES Complete
2008 R44 RFA-CA-07-008 DOLINGER, DAVID LEE IQUUM, INC. RAPID POINT-OF-CARE ASSAY FOR DETECTING HIGH RISK HUMAN PAPILLOMAVIRUS Complete
2021 R44 PAR-18-303 HUNG, PAUL JU-SUNG COMBINATI, INC. Digital Melt Curve Analysis Platform for Longitudinal Cancer Patient Monitoring Complete
2016 R44 PAR-13-327 KARSTEN, STANISLAV NEUROINDX INC. Automated Platform for Fixed Tissue Microdissection Complete
2020 R44 PAR-18-303 GURARD-LEVIN, ZACHARY SAMDI TECH, INC. Development Of The First Label-free And High-throughput, Cell-based Assay That Reports On Specific Enzyme Activities Complete
2016 R44 PAR-13-327 JOHNSON, DAVID SCOTT GIGAGEN, INC. Next-Generation Antibody Discovery and Development Technology Complete

Pages